Case Studies
Medialis has supported clients promoting a medicines for the treatment of type 2 diabetes, XLH, cancer, cardiac and neurological disorders and a variety of rare diseases
“The Impact of Candidate Influenza Virus and Egg-Based Manufacture on Vaccine Effectiveness”
Currently, influenza vaccine manufacturing using embryonated hen’s eggs remains the most common vaccine production method, primarily due to historical factors, the availability of supply, and lower costs.
Medialis generated a strategic manuscript highlighting the importance of weight in the management of Type 2 diabetes
The client promoted a medicine for the treatment of type 2 diabetes, …
Medialis successfully differentiated AZ (QW) GLP-1 within the GLP-1 class
Medialis devised a method to construct the ‘optimal’ characteristics of a GLP-1 given a range of characteristics from real products.
Medialis differentiated GSK- ERA within the Endothelin Receptor Antagonist Class
The endothelin receptor class of medicines is used to treat class II and III PAH.
Medialis differentiated TKI -G within the tyrosine kinase class
Three meta-analyses were conducted, which showed that in terms of efficacy, the three members were indeed equivalent, approved for treating of EGFR+ve non small cell lung cancer
Medialis built the Breakthrough Cancer Pain (BTcP) market
Medialis carried out full training for the sales force and implemented 1:1 online briefings for key customers. An electronic and paper leave pieces were also produced.